MedPath

Lactose

Generic Name
Lactose
Drug Type
Small Molecule
Chemical Formula
C12H22O11
CAS Number
63-42-3
Unique Ingredient Identifier
3SY5LH9PMK
Background

A disaccharide of glucose and galactose in human and cow milk. It is used in pharmacy for tablets, in medicine as a nutrient, and in industry.

Indication

Not Available

Associated Conditions
Asthma, Chronic Obstructive Pulmonary Disease (COPD), Hypothyroidism, Opioid Dependence, Thyroid Cancer
Associated Therapies
Maintenance treatment, opioids, Opioid Detoxification

Effect of Tiotropium Inhalation Capsules on Exercise Tolerance, Daily Activity and Dyspnoea in Patients With Chronic Obstructive Pulmonary Disease (COPD) Participating in 3 Weeks of Pulmonary Rehabilitation

Phase 4
Terminated
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
First Posted Date
2014-06-24
Last Posted Date
2014-06-24
Lead Sponsor
Boehringer Ingelheim
Target Recruit Count
15
Registration Number
NCT02172508

Efficacy of Sodium Polystyrene Sulfonate in the Treatment of Hyperkaliemia in Pre-dialysis Patients

Phase 4
Completed
Conditions
Hyperkalemia
Chronic Kidney Failure
Interventions
First Posted Date
2014-02-17
Last Posted Date
2014-10-03
Lead Sponsor
Maisonneuve-Rosemont Hospital
Target Recruit Count
38
Registration Number
NCT02065076
Locations
🇨🇦

Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada

A Dietary Supplement for Early Cigarette Withdrawal

Phase 2
Completed
Conditions
Nicotine Dependence, Cigarettes, With Withdrawal
Interventions
Drug: Dietary Supplement
First Posted Date
2014-01-23
Last Posted Date
2018-02-14
Lead Sponsor
Centre for Addiction and Mental Health
Target Recruit Count
21
Registration Number
NCT02042521
Locations
🇨🇦

Centre for Addiction and Mental Health, Toronto, Ontario, Canada

Does a Perioperative Course of Gabapentin Improve Analgesia After Cesarean Delivery?

Not Applicable
Completed
Conditions
Pain
Interventions
First Posted Date
2013-05-07
Last Posted Date
2014-10-13
Lead Sponsor
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Target Recruit Count
204
Registration Number
NCT01848119
Locations
🇨🇦

Mount Sinai Hospital, Toronto, Ontario, Canada

The Effects of Atorvastatin Treatment in COPD Patients

Phase 4
Completed
Conditions
COPD
Interventions
First Posted Date
2012-12-12
Last Posted Date
2013-04-23
Lead Sponsor
Medical University of Bialystok
Target Recruit Count
18
Registration Number
NCT01748279
Locations
🇵🇱

Department of Lung Diseases and Tuberculosis, Medical University of Bialystok, Bialystok, Poland

Comparing the Efficacy of Pregabalin and Hydroxyzine on the Anxiety Score

Phase 2
Completed
Conditions
Feeling Anxious
Interventions
First Posted Date
2012-08-30
Last Posted Date
2016-10-11
Lead Sponsor
Poitiers University Hospital
Target Recruit Count
306
Registration Number
NCT01675986
Locations
🇫🇷

CHU de POITIERS, Poitiers, France

The Effect of Aspirin on REducing iNflammation in Human in Vivo Model of Acute Lung Injury

Phase 2
Completed
Conditions
Acute Lung Injury
Interventions
First Posted Date
2012-08-07
Last Posted Date
2022-09-13
Lead Sponsor
Belfast Health and Social Care Trust
Target Recruit Count
33
Registration Number
NCT01659307
Locations
🇬🇧

Belfast Health and Social Care Trust, Belfast, United Kingdom

A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen

Phase 2
Completed
Conditions
Parainfluenza
Interventions
Drug: DAS181 dry powder, formulation F02
First Posted Date
2012-07-19
Last Posted Date
2017-09-25
Lead Sponsor
Ansun Biopharma, Inc.
Target Recruit Count
111
Registration Number
NCT01644877
Locations
🇺🇸

Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

🇺🇸

Lurie Children's Hospital, Chicago, Illinois, United States

🇺🇸

University of Chicago, Chicago, Illinois, United States

and more 42 locations

The Effect of Melatonin on Nocturnal Enuresis

Phase 2
Conditions
Nocturnal Enuresis
Interventions
First Posted Date
2012-04-11
Last Posted Date
2012-11-02
Lead Sponsor
University of Aarhus
Target Recruit Count
40
Registration Number
NCT01575678
Locations
🇩🇰

Center of Child Incontinence, Pediatric department, Aarhus Universityhospital, Aarhus, Region Midtjylland, Denmark

Allopurinol in Functional Impairment (ALFIE) Trial: 'Improving Muscle Strength'

Phase 4
Completed
Conditions
Sarcopenia
Interventions
First Posted Date
2012-03-09
Last Posted Date
2018-03-20
Lead Sponsor
University of Dundee
Target Recruit Count
124
Registration Number
NCT01550107
Locations
🇬🇧

University of Dundee Medical School, Dundee, Angus, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath